Press "Enter" to skip to content

New patent expiration for Keryx Biopharms drug AURYXIA

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Keryx Biopharms drug AURYXIA

Annual Drug Patent Expirations for AURYXIA
Annual Drug Patent Expirations for AURYXIA

Auryxia is a drug marketed by Keryx Biopharms and is included in one NDA. It is available from one supplier. There are fourteen patents protecting this drug.

AURYXIA drug price trends.

Drug patent litigation for AURYXIA.

This drug has one hundred and twelve patent family members in twenty-six countries.

The generic ingredient in AURYXIA is ferric citrate. One supplier is listed for this compound. Additional details are available on the ferric citrate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent expiration for Keryx Biopharms drug AURYXIA
    Do NOT follow this link or you will be banned from the site!